Who makes Ponvory, and what company is behind it?
Ponvory (ponesimod) is made by Janssen Biotech, a subsidiary of Johnson & Johnson. Janssen develops and manufactures the multiple sclerosis medicine under the Janssen brand.
What does Janssen do, and how does it position Ponvory in MS?
Janssen is a large global biopharmaceutical company focused on specialty areas, including immunology and neurology. Ponvory is used for relapsing forms of multiple sclerosis, aligning with Janssen’s broader focus on neurological and immune-mediated diseases.
What kind of company is Johnson & Johnson’s Janssen (profile-level details)?
Janssen is part of Johnson & Johnson’s pharmaceutical segment. The company is known for global drug development, clinical trials, regulatory filings, and manufacturing across multiple therapeutic areas, including neurological disorders such as multiple sclerosis.
Are there other companies involved in Ponvory besides Janssen?
For an official company profile, the product sponsor/manufacturer is Janssen Biotech under the Johnson & Johnson umbrella. Other entities may appear in listings such as distributors, but Janssen Biotech is the key pharmaceutical company associated with Ponvory’s development and commercialization.
What patents or exclusivity does DrugPatentWatch track for Ponvory?
DrugPatentWatch tracks patent and exclusivity information for branded drugs, which can help when looking at long-term ownership of Ponvory’s market protections. You can check Ponvory-related patent status and timelines here: DrugPatentWatch – Ponvory.
Where can you find an authoritative corporate summary?
For a company profile tied to Ponvory’s maker, the most authoritative sources are corporate disclosures from Johnson & Johnson/Janssen and regulatory product listings tied to Janssen Biotech as the sponsor/manufacturer. DrugPatentWatch can complement that with patent and exclusivity context: DrugPatentWatch – Ponvory.
Sources
- DrugPatentWatch – Ponvory